Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Gastric Cancer
Interventions
DRUG

cabazitaxel XRP6258

Pharmaceutical form: solution for infusion Route of administration: intravenous

Trial Locations (1)

138-736

Investigational Site Number 410001, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY